[144] Golden Sun Health Technology Group Limited SEC Filing

Rhea-AI Filing Summary

Form 144 notice by an insider of Golden Sun Health Technology Group Limited (GSUN) reporting a proposed sale of Class A ordinary shares. The filing lists a proposed sale of 140,108 Class A ordinary shares through WestBull Securities Limited (Hong Kong) on the Nasdaq with an aggregate market value of $378,291.60 and 1,577,944 shares outstanding reported. The table discloses prior acquisitions of Class A shares: 14,460 shares purchased 04/02/2020, 57,840 shares purchased 10/19/2020, and 4,820 shares purchased 10/19/2020, with payment in USD. The filer attests they possess no undisclosed material adverse information and includes the standard Rule 144 and signature attestations.

Insights

Securities Analyst

TL;DR: Insider intends to sell 140,108 GSUN Class A shares (~$378k) via WestBull on Nasdaq; disclosure is routine under Rule 144.

The filing is a standard Rule 144 notice outlining a proposed sale and the acquisition history for the securities to be sold. It provides the broker, planned sale date (08/29/2025), aggregate value, and outstanding share count. No financial results, material events, or additional context are included, so the filing itself does not change the company's fundamentals but signals insider liquidity.

Corporate Governance Expert

TL;DR: The disclosure meets Rule 144 formalities; signer certifies absence of undisclosed material information.

The form contains the required attestation language and acquisition details for the securities being offered. It indicates reliance on Rule 144 mechanics and includes broker information. There are no statements of insider trading plans (e.g., 10b5-1 adoption dates) or other governance notes in the filing, so governance implications are limited to routine disclosure obligations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Ordinary Shares	WestBull Securities Limited HongKong Unit 2701-03, 27/F Infinitus Plaza 199 Des Voeux Road Central K3 000000	140108	378291.60	1577944	08/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	04/02/2020	Purchase of shares	Weng Xueyuan			14460	04/02/2020	USD
Class A	10/19/2020	Purchase of shares	Weng Xueyuan			57840	04/02/2020	USD
Class A	10/19/2020	Purchase of shares	Dragon Vantage Industrial Limited			4820	04/02/2020	USD

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by GSUN disclose?

The Form 144 discloses a proposed sale of 140,108 Class A ordinary shares via WestBull Securities on Nasdaq with an aggregate market value of $378,291.60 and reports 1,577,944 shares outstanding.

When is the proposed sale scheduled for GSUN shares?

The filing lists the approximate date of sale as 08/29/2025.

Who is the broker handling the proposed GSUN sale?

The broker listed is WestBull Securities Limited, Hong Kong (unit and address provided in the filing).

What acquisition history is reported for the shares to be sold?

The filing reports acquisitions of Class A shares: 14,460 on 04/02/2020, 57,840 on 10/19/2020, and 4,820 on 10/19/2020, with payment in USD.

Does the filer state there is undisclosed material information?

The filer signs the standard attestation stating they do not know any material adverse information regarding the issuer that has not been publicly disclosed.